Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    WEKA and Andromeda Partner to Power AI Workloads at Global Scale

    July 30, 2026

    Continuity Biosciences Appoints Vicky Papoutsis to Board of Directors

    July 30, 2026

    Apple market cap reaches 4.94 trillion to top Nvidia

    July 29, 2026
    Facebook X (Twitter) Instagram
    • Home
    • Contact Us
    News of ZionNews of Zion
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • More
      • Sports
      • Technology
      • Travel
    News of ZionNews of Zion
    Home » ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market
    Featured News

    ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

    May 18, 2023
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    BUFFALO, NY / ACCESSWIRE / May 16, 2023 / ZeptoMetrix® is excited to introduce PROtrol TM, a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic a true clinical specimen and can be used to evaluate and monitor the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases.

    ZeptoMetrix logo
    ZeptoMetrix logo

    PROtrol is the only whole organism reference material to provide complete testing data. Each lot of product is supplied with the protein concentration and TCID50 value, which minimizes qualification testing. PROtrol provides better reproducibility, which optimizes the use of financial spending and processing time through the decreased need for repeat testing.

    “The rapid expansion in development of antigen-based assays has highlighted some quality challenges. Inactivated, whole organism controls designed specifically for antigen tests can equip manufacturers with the tools they need to better evaluate the performance of their assays, leading to higher quality tests on the market,” said Dr. Karuna Sharma, Vice President & Chief Scientific Officer.

    PROtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Isolate: USA-WA1/2020* is the first member of this product line (PROSARS(COV2)-587). As we move beyond the COVID-19 pandemic, ZeptoMetrix will continue to grow the PROtrol product line, providing high-quality controls to assay manufacturers seeking to expand access to inexpensive and easy-to-use diagnostics.

    “The launch and expansion of PROtrol enhances our position as the partner of choice for diagnostic test developers,” said Evangeline Gonzalez, President of Antylia Diagnostics division. “As we work with our diagnostic partners, ZeptoMetrix is pleased with the role that PROtrol plays to give patients around the world more access to diagnostic testing.”

    More information on how to order the new PROtrol and additional ZeptoMetrix products can be found at: https://www.zeptometrix.com

    About ZeptoMetrix®
    ZeptoMetrix® is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Our expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services have set the industry standard for performance and reliability and make ZeptoMetrix the preferred choice for independent third-party quality control materials.

    Links:
    * (PROSARS(COV2)-587): product page
    https://www.zeptometrix.com/products/protrolt-sars-cov-2-isolate-usa-wa1-2020-1-ml

    Contact Information

    Andrew Zenger
    Global Product Manager
    andrew.zenger@antylia.com
    (716) 715-7417

    Related Files

    PROSARS(COV2)-587 Product Insert.pdf
    ZeptoMetrix Launches PROtrol.pdf

    SOURCE: ZeptoMetrix

    .

    ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email

    Related Posts

    XERF arrives in Dubai as Biolite Clinic leads Middle East launch

    July 23, 2026

    ART Elite Car Rental Announces Its Fleet Expansion with 300+ Jetour Vehicles

    June 26, 2026

    The Evolution of a Leader: From the Pitch to Global Brand Ambassadorship

    June 9, 2026

    SPIEF 2026 Energy Panel Highlights Global Economic Transformation

    June 8, 2026

    ThinkMarkets launches ChelseaAI, bringing live CFD trading into AI assistants

    June 2, 2026

    Kerno Showcases UAE-Built Sovereign Compute Platform at MIITE 2026

    May 4, 2026
    Editor's Pick

    Apple market cap reaches 4.94 trillion to top Nvidia

    July 29, 2026

    The valuation shift reflects broader recalibrations across international financial markets as institutional managers re-evaluate capital commitments tied to artificial intelligence infrastructure. While competing hyperscale computing enterprises including Alphabet and Tesla accelerated capital investments toward data centers, robotics, and autonomous transport networks, Apple maintained disciplined expenditure controls over consecutive fiscal quarters. Market participants increasingly view Apple’s disciplined spending approach as a operational buffer, allowing the firm to expand its proprietary Apple Intelligence software ecosystem without incurring high infrastructure depreciation costs. Trading patterns across major equity benchmarks highlighted diverging sentiment between hardware component suppliers and consumer technology platforms. Nvidia shares experienced increased selling pressure alongside wider pullbacks across semiconductor equities, as investors scrutinized the timeline for financial returns on massive artificial intelligence data center investments. The Philadelphia Semiconductor Index recorded notable weekly declines as market participants reassessed elevated valuation multiples across pure-play chipmakers. Despite persistent demand for graphics processing units, concerns surrounding energy supply constraints, macroeconomic interest rate trajectories, and capital expenditure intensity weighed on semiconductor equity prices.

    Gold prices fall on strong dollar ahead of central bank meeting

    July 29, 2026

    Porsche to cut 5000 more jobs under restructuring plan

    July 28, 2026

    Senate crypto bill faces pushback over conflict of interest rules

    July 28, 2026

    May foreign tourist arrivals drive South Korea travel surplus

    July 27, 2026

    Extreme heat wave triggers emergency alerts across Daegu

    July 27, 2026

    Heat intensifies severe drought across European nations

    July 24, 2026
    © 2026 News of Zion | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.